Publications by authors named "Anjali K I"
Exploring chitosan nanoparticles for enhanced therapy in neurological disorders: a comprehensive review.
Naunyn Schmiedebergs Arch Pharmacol
October 2024
Article Synopsis
- Chitosan nanoparticles are gaining attention as a therapeutic option for neurological disorders due to their biocompatibility, biodegradability, and ability to be easily modified for targeted drug delivery.
- These nanoparticles help overcome the blood-brain barrier, crucial for treating conditions like Alzheimer’s, Parkinson’s, and brain tumors, by enhancing drug absorption and protecting therapies from degradation.
- While promising results have been observed in animal studies, challenges such as large-scale production, regulatory issues, and the need for safety research still exist for their clinical use.